Javascript must be enabled to continue!
Immunodeficiency
View through CrossRef
Abstract
Immunodeficiency is a condition caused by a defect in the immune system, leading to a failure to protect the body adequately from infection. It should be considered in anybody with a history of recurrent infections, two or more episodes of life‐threatening infections, infections with unusual or opportunistic organisms or with unexpected or severe complications. Immunodeficiency may be either primary or secondary in origin.
Primary immunodeficiency (PID) may present as early as the first 3–4 weeks of life with severe diarrhoea, resulting in failure to thrive, recurrent infections and severe eczema. However, it may also manifest in early childhood or later, depending on the nature of the underlying disease and genetic mutation. It is essential to diagnose PID early, particularly severe combined immune deficiency (SCID), in order to prevent infections and organ damage and offer curative treatment such as haematopoietic stem cell transplantation (HSCT) or gene transfer (GT).
Key Concepts
Defects in the immune system can put patients at risk of life‐threatening infections.
Primary immunodeficiency consists of a wide range of disorders that affect adaptive or innate immunity.
Early diagnosis of primary immunodeficiency is essential for successful outcome.
The most common manifestation of immunodeficiency is recurrent respiratory infections.
The most predictive of 10 warning signs for a diagnosis of PID are family history, need for intravenous antibiotics for sepsis and failure to thrive.
Next‐generation sequencing has led to the discovery of novel genetic causes of known and new PIDs.
Outcome of haematopoietic stem cell transplantation has greatly improved.
Gene therapy is successful and increasingly available for a number of disorders.
Secondary immunodeficiency can be caused by infection such as HIV.
Title: Immunodeficiency
Description:
Abstract
Immunodeficiency is a condition caused by a defect in the immune system, leading to a failure to protect the body adequately from infection.
It should be considered in anybody with a history of recurrent infections, two or more episodes of life‐threatening infections, infections with unusual or opportunistic organisms or with unexpected or severe complications.
Immunodeficiency may be either primary or secondary in origin.
Primary immunodeficiency (PID) may present as early as the first 3–4 weeks of life with severe diarrhoea, resulting in failure to thrive, recurrent infections and severe eczema.
However, it may also manifest in early childhood or later, depending on the nature of the underlying disease and genetic mutation.
It is essential to diagnose PID early, particularly severe combined immune deficiency (SCID), in order to prevent infections and organ damage and offer curative treatment such as haematopoietic stem cell transplantation (HSCT) or gene transfer (GT).
Key Concepts
Defects in the immune system can put patients at risk of life‐threatening infections.
Primary immunodeficiency consists of a wide range of disorders that affect adaptive or innate immunity.
Early diagnosis of primary immunodeficiency is essential for successful outcome.
The most common manifestation of immunodeficiency is recurrent respiratory infections.
The most predictive of 10 warning signs for a diagnosis of PID are family history, need for intravenous antibiotics for sepsis and failure to thrive.
Next‐generation sequencing has led to the discovery of novel genetic causes of known and new PIDs.
Outcome of haematopoietic stem cell transplantation has greatly improved.
Gene therapy is successful and increasingly available for a number of disorders.
Secondary immunodeficiency can be caused by infection such as HIV.
Related Results
Interactions Between Human Immunodeficiency Virus–1, Hepatitis Delta Virus and Hepatitis B Virus Infections in 260 Chronic Carriers of Hepatitis B Virus
Interactions Between Human Immunodeficiency Virus–1, Hepatitis Delta Virus and Hepatitis B Virus Infections in 260 Chronic Carriers of Hepatitis B Virus
To evaluate the factors determining the severity of chronic hepatitis B virus infection and the interactions of human immunodeficiency virus and hepatitis delta virus infections, w...
Somatic mutations and T-cell clonality in patients with immunodeficiency
Somatic mutations and T-cell clonality in patients with immunodeficiency
Common variable immunodeficiency and other late-onset immunodeficiencies often co-manifest with autoimmunity and lymphoproliferation. The pathogenesis of most cases is elusive, as ...
PREVALENCE OF HEPATITIS C VIRUS AND HUMAN IMMUNODEFICIENCY VIRUS IN INJECTION DRUG USERS OF KHYBER PAKHTUNKHWA, AND FACTORS AFFECTING ITS OCCURRENCE
PREVALENCE OF HEPATITIS C VIRUS AND HUMAN IMMUNODEFICIENCY VIRUS IN INJECTION DRUG USERS OF KHYBER PAKHTUNKHWA, AND FACTORS AFFECTING ITS OCCURRENCE
Objective: Our main objective was to find out the prevalence of Hepatitis C virus and Human immunodeficiency virus and its co presence in injection drug users. We have to show the ...
SPECTRUM OF PRIMARY IMMUNODEFICIENCY DISORDERS IN CHILDREN IN KASHMIR
SPECTRUM OF PRIMARY IMMUNODEFICIENCY DISORDERS IN CHILDREN IN KASHMIR
Primary immunodeficiency disorders (PIDs) are a genetically heterogeneous group of disorders that affect distinct components of the innate and adaptive immune system. To date, more...
HIV/AIDS treatment failure and associated factors in Ethiopia: Meta-analysis
HIV/AIDS treatment failure and associated factors in Ethiopia: Meta-analysis
Abstract
Background: The national burden of human immunodeficiency virus treatment failure and associated factors in the Ethiopian context is required to provide evidence t...
Overnutrition and its associated factors among adult human immunodeficiency virus positive patients on antiretroviral therapy, Northwest, Ethiopia
Overnutrition and its associated factors among adult human immunodeficiency virus positive patients on antiretroviral therapy, Northwest, Ethiopia
Background: Anti-retroviral therapy was introduced to treat human immunodeficiency virus patients; comorbidities affecting individuals with human immunodeficiency virus-positive ha...
HIV/AIDS treatment failure and associated factors in Ethiopia: meta-analysis
HIV/AIDS treatment failure and associated factors in Ethiopia: meta-analysis
Abstract
Background
The national burden of human immunodeficiency virus treatment failure and associated factors in the E...
The first report of kidney transplantation in a human immunodeficiency virus–positive recipient in Thailand and literature review: Encouragement for developing countries in Southeast Asia
The first report of kidney transplantation in a human immunodeficiency virus–positive recipient in Thailand and literature review: Encouragement for developing countries in Southeast Asia
Patients with human immunodeficiency virus infection are at risk of chronic kidney disease and end-stage renal disease. Human immunodeficiency virus infection impedes patients’ acc...

